|
|
![The closer the better with cTACE]()
|
|
Why each cTACE should be a super selective cTACE?
|
|
|
By regenerating cTACE technique
through procedure standardization and
super selective catheterization approach1,
patient overall survival is positively
impacted1 and in specific cases*, a
patient having a HCC with an irregular
margin suggesting the absence of a
pseudo capsule showing a well
controlled tumor after 6 years2, or in a
patient presenting originally three tumor-feeders, showing a well controlled
tumor after 10 years and 4 months3.
|
![watch how Roberto lezzi practices cTACEin complex HCC cases.]()
|
|
If you are seeking to develop a proven practice in HCC management at early
and intermediate stages, or if you would like to learn more about super selective cTACE,
CONTACT US!
|
| 1. |
Thierry de Baere et al. Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE) Cardiovasc Intervent Radiol (2022) 45:1430–1440
|
| 2. |
Shiro Miyayama MD, and Osamu Matsui, MD Superselective Conventiona Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome J Vasc. Interv. Radiol. 2016; 27:1269–1278
|
| 3. |
Shiro MiyayamaUltraselective conventional transarteriall chemoembolization: When and how? Clinical and Molecular Hepatology 2019; 25:344-353
|
|
|
*These specific cases are based on the results achieved in unique scientific or clinical setting. Individual results may vary because each patient and case are unique, there is no guarantee of any particular result for any specific patient.
|
|
Product legal information
|
|
|
|
|
